In a regulatory filing, ResMed president of Asia Latin America Justin Leong disclosed the sale of 48,000 common shares of the company on August 5 at a price of $217.074 per share.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RMD: